"After five lean years, transactions in the healthcare market rebounded spectacularly last year. But the recovery is far from uniform: investors are favoring the most advanced assets and therapeutic modalities deemed promising."
Emmanuelle Trombe comments in L'Agefi. To read the full article (via paywall), click here.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
